Celldex Therapeutics Inc.. (CLDX) NASDAQ
$37.02 (0.75) (-1.99%)
Market Cap: $2.07B
As of 04/24/24 04:00 PM EDT. Market closed.
Celldex Therapeutics Inc.. (CLDX)
NASDAQ
$37.02
(0.75) (-1.99%)
Market Cap: $2.07B
As of 04/24/24 04:00 PM EDT. Market closed.
Add to Portfolio
celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response. celldex therapeutics (nasdaq: cldx) was ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Anthony Marucci
Full Time Employees
163
CEO Compensation (Base)
$597,569
CEO Compensation (Total)
$1.66M
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Anthony Marucci
Full Time Employees
163
CEO Compensation (Base)
$597,569
CEO Compensation (Total)
$1.66M
URL
Address
53 Frontage Rd Ste 220, New Jersey, Hampton, 08827-4034.
PRICE CHART FOR CELLDEX THERAPEUTICS INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$37.77
Days Range
$36.96 - $37.87
52 week range
$22.11 - $53.18
Volume
394,653
Avg. Volume (30 days)
613,517
Market Cap
$2.07B
Dividend Yield
-
P/E
(14.63)
Shares Outstanding
55,900,679
Open
-
Previous Close
$37.77
Days Range
$36.96 - $37.87
52 week range
$22.11 - $53.18
Volume
394,653
Avg. Volume (30 days)
613,517
Market Cap
$2.07B
Dividend Yield
-
P/E
(14.63)
Shares Outstanding
55,900,679
FINANCIAL STATEMENTS FOR CELLDEX THERAPEUTICS INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CELLDEX THERAPEUTICS INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Jimenez Freddy A. | SVP & GENERAL COUNSEL | Feb 13, 2024 | Option Exercise | $3.86 | 24,166 | 93,163 | 25,924 | Feb 15, 2024, 04:05 PM |
| Martin Samuel Bates | SVP AND CFO | Jan 02, 2024 | Option Exercise | $2.78 | 10,750 | 29,885 | 35,128 | Jan 04, 2024, 04:05 PM |
| KELER TIBOR | EXECUTIVE VP & CSO | Dec 07, 2022 | Option Exercise | $2.78 | 16,860 | 46,871 | 24,217 | Dec 09, 2022, 04:07 PM |
| KELER TIBOR | EXECUTIVE VP & CSO | Dec 07, 2022 | Sale | $36.93 | 16,860 | 622,611 | 7,357 | Dec 09, 2022, 04:07 PM |
| Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | Aug 18, 2022 | Option Exercise | $9.02 | 1,355 | 12,217 | 2,639 | Aug 19, 2022, 04:06 PM |
| Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | Aug 17, 2022 | Option Exercise | $2.78 | 31,312 | 87,047 | 32,596 | Aug 19, 2022, 04:06 PM |
| Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | Aug 17, 2022 | Sale | $36.73 | 31,312 | 1,150,221 | 1,284 | Aug 19, 2022, 04:06 PM |
| Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | Aug 18, 2022 | Sale | $36.38 | 1,355 | 49,289 | 1,284 | Aug 19, 2022, 04:06 PM |
| Young Diane C. | SVP, CHIEF MEDICAL OFFICER | Aug 17, 2022 | Option Exercise | $4.99 | 64,000 | 319,170 | 47,115 | Aug 19, 2022, 04:05 PM |
| Young Diane C. | SVP, CHIEF MEDICAL OFFICER | Aug 17, 2022 | Sale | $37.30 | 19,000 | 708,715 | 2,115 | Aug 19, 2022, 04:05 PM |
| Wright Richard M. | SR. VP & CCO | Aug 15, 2022 | Option Exercise | $10.38 | 15,328 | 159,105 | 15,536 | Aug 17, 2022, 04:05 PM |
| Wright Richard M. | SR. VP & CCO | Aug 15, 2022 | Sale | $37.71 | 15,328 | 578,048 | 208 | Aug 17, 2022, 04:05 PM |
| Martin Samuel Bates | SVP AND CFO | Aug 12, 2022 | Option Exercise | $4.16 | 17,547 | 72,953 | 41,925 | Aug 15, 2022, 04:16 PM |
| Martin Samuel Bates | SVP AND CFO | Aug 11, 2022 | Option Exercise | $9.02 | 2,453 | 22,117 | 26,831 | Aug 15, 2022, 04:16 PM |
| Martin Samuel Bates | SVP AND CFO | Aug 12, 2022 | Sale | $36.45 | 17,547 | 639,629 | 27,664 | Aug 15, 2022, 04:16 PM |
| Martin Samuel Bates | SVP AND CFO | Aug 11, 2022 | Sale | $37.04 | 2,453 | 90,856 | 24,378 | Aug 15, 2022, 04:16 PM |
| Martin Samuel Bates | SVP and CFO | Dec 23, 2021 | Option Exercise | $5.68 | 7,000 | 39,729 | 33,878 | Dec 28, 2021, 04:02 PM |
| Martin Samuel Bates | SVP and CFO | Dec 23, 2021 | Sale | $42.00 | 9,500 | 399,000 | 24,378 | Dec 28, 2021, 04:02 PM |
| Cavanaugh Sarah | SVP of Corp Affairs & Admin. | Dec 08, 2021 | Option Exercise | $10.03 | 7,323 | 73,481 | 7,731 | Dec 10, 2021, 04:03 PM |
| Cavanaugh Sarah | SVP of Corp Affairs & Admin. | Dec 08, 2021 | Sale | $40.00 | 7,323 | 292,920 | 408 | Dec 10, 2021, 04:03 PM |
| Crowley Elizabeth | Sr. VP &CPDO | Dec 08, 2021 | Option Exercise | $9.02 | 4,000 | 36,066 | 8,726 | Dec 10, 2021, 04:02 PM |
| Crowley Elizabeth | Sr. VP &CPDO | Dec 08, 2021 | Sale | $40.00 | 4,000 | 160,000 | 4,726 | Dec 10, 2021, 04:02 PM |
| Heath-Chiozzi Margo | SVP of Regulatory Affairs | Dec 08, 2021 | Option Exercise | $2.78 | 600 | 1,668 | 11,847 | Dec 10, 2021, 04:02 PM |
| Heath-Chiozzi Margo | SVP of Regulatory Affairs | Dec 08, 2021 | Sale | $40.00 | 600 | 24,000 | 11,247 | Dec 10, 2021, 04:02 PM |
| Martin Samuel Bates | SVP and CFO | Nov 15, 2021 | Option Exercise | $5.68 | 7,000 | 39,729 | 36,378 | Nov 17, 2021, 04:02 PM |
| Martin Samuel Bates | SVP and CFO | Nov 15, 2021 | Sale | $43.57 | 9,500 | 413,883 | 28,926 | Nov 17, 2021, 04:02 PM |
| Young Diane C. | SVP, Chief Medical Officer | Nov 12, 2021 | Option Exercise | $10.38 | 4,600 | 47,748 | 6,715 | Nov 16, 2021, 04:02 PM |
| Young Diane C. | SVP, Chief Medical Officer | Nov 12, 2021 | Sale | $42.94 | 4,600 | 197,529 | 2,115 | Nov 16, 2021, 04:02 PM |
| Cavanaugh Sarah | SVP of Corp Affairs & Admin. | Nov 01, 2021 | Option Exercise | $8.03 | 5,956 | 47,852 | 7,731 | Nov 03, 2021, 04:02 PM |
| Cavanaugh Sarah | SVP of Corp Affairs & Admin. | Nov 01, 2021 | Sale | $43.26 | 7,323 | 316,804 | 3,429 | Nov 03, 2021, 04:02 PM |
| Crowley Elizabeth | Sr. VP &CPDO | Nov 01, 2021 | Option Exercise | $2.78 | 8,555 | 23,783 | 9,043 | Nov 03, 2021, 04:02 PM |
| Crowley Elizabeth | Sr. VP &CPDO | Nov 01, 2021 | Sale | $43.29 | 4,317 | 186,874 | 6,515 | Nov 03, 2021, 04:02 PM |
| Heath-Chiozzi Margo | SVP of Regulatory Affairs | Nov 01, 2021 | Option Exercise | $2.78 | 600 | 1,668 | 11,847 | Nov 03, 2021, 04:02 PM |
| Heath-Chiozzi Margo | SVP of Regulatory Affairs | Nov 01, 2021 | Sale | $41.71 | 600 | 25,026 | 11,247 | Nov 03, 2021, 04:02 PM |
| Heath-Chiozzi Margo | SVP of Regulatory Affairs | Aug 11, 2021 | Option Exercise | $9.02 | 10,000 | 90,165 | 11,247 | Aug 13, 2021, 06:59 AM |
| Jimenez Freddy A. | SVP & General Counsel | Aug 11, 2021 | Buy | $46.28 | 430 | 19,900 | 430 | Aug 13, 2021, 06:58 AM |
| Martin Samuel Bates | SVP and CFO | Aug 10, 2021 | Option Exercise | $5.78 | 21,381 | 123,688 | 30,060 | Aug 12, 2021, 10:00 AM |
| Martin Samuel Bates | SVP and CFO | Aug 10, 2021 | Sale | $45.25 | 2,738 | 123,895 | 29,378 | Aug 12, 2021, 10:00 AM |
| Marucci Anthony S | President & CEO | Aug 05, 2021 | Option Exercise | $42.00 | 3,537 | 148,554 | 27,231 | Aug 09, 2021, 07:21 AM |
| Wright Richard M. | Sr. VP & CCO | Dec 14, 2020 | Option Exercise | $6.21 | 20,832 | 129,365 | 11,665 | Dec 16, 2020, 04:30 PM |
| Wright Richard M. | Sr. VP & CCO | Dec 14, 2020 | Sale | $18.61 | 20,832 | 387,611 | 208 | Dec 16, 2020, 04:30 PM |
| Young Diane C. | SVP, Chief Medical Officer | Jun 11, 2020 | Buy | $4.73 | 2,115 | 10,004 | 2,115 | Jun 12, 2020, 07:55 AM |
| Cavanaugh Sarah | SVP of Corp Affairs & Admin. | Jun 10, 2020 | Buy | $4.83 | 1,050 | 5,071 | 1,367 | Jun 11, 2020, 07:54 AM |
| Heath-Chiozzi Margo | SVP of Regulatory Affairs | Jun 09, 2020 | Buy | $3.01 | 1,000 | 3,005 | 1,000 | Jun 10, 2020, 07:55 AM |
| Martin Samuel Bates | SVP and CFO | Jun 09, 2020 | Buy | $3.05 | 9,750 | 29,737 | 10,735 | Jun 10, 2020, 07:55 AM |
| MARINO JAMES J | Director | Jun 09, 2020 | Buy | $3.00 | 8,305 | 24,915 | 12,704 | Jun 10, 2020, 07:54 AM |
| KELER TIBOR | Executive VP & CSO | Jun 09, 2020 | Buy | $2.99 | 5,000 | 14,954 | 7,357 | Jun 10, 2020, 07:54 AM |
| Marucci Anthony S | President & CEO | Jun 09, 2020 | Buy | $3.06 | 15,000 | 45,900 | 19,438 | Jun 10, 2020, 07:54 AM |
| McMahon Gerald PhD | Director | Dec 03, 2018 | Option Exercise | $0.30 | 2,824 | 843 | 180,697 | Dec 04, 2018, 07:35 AM |
| McMahon Gerald PhD | Director | Nov 01, 2018 | Option Exercise | $0.31 | 2,888 | 908 | 183,521 | Nov 02, 2018, 07:50 AM |
| McMahon Gerald PhD | Director | Oct 01, 2018 | Option Exercise | $0.45 | 2,888 | 1,302 | 186,409 | Oct 02, 2018, 07:32 AM |
| McMahon Gerald PhD | Director | Sep 04, 2018 | Option Exercise | $0.50 | 2,813 | 1,412 | 189,297 | Sep 05, 2018, 07:59 AM |
| MARINO JAMES J | Director | Aug 24, 2018 | Buy | $0.48 | 40,000 | 19,200 | 65,997 | Aug 28, 2018, 07:34 AM |
| McMahon Gerald PhD | Director | Aug 01, 2018 | Option Exercise | $0.47 | 2,813 | 1,308 | 192,110 | Aug 02, 2018, 07:55 AM |
| McMahon Gerald PhD | Director | Jul 02, 2018 | Option Exercise | $0.50 | 2,813 | 1,417 | 194,923 | Jul 03, 2018, 07:43 AM |
| KELER TIBOR | Executive VP & CSO | Jun 15, 2018 | Buy | $0.59 | 16,500 | 9,783 | 35,368 | Jun 18, 2018, 08:15 AM |
| McMahon Gerald PhD | Director | Jun 01, 2018 | Option Exercise | $0.58 | 2,813 | 1,632 | 197,736 | Jun 04, 2018, 08:15 AM |
| McMahon Gerald PhD | Director | May 01, 2018 | Option Exercise | $0.74 | 2,813 | 2,082 | 200,549 | May 02, 2018, 07:16 AM |
| McMahon Gerald PhD | Director | Apr 02, 2018 | Option Exercise | $2.33 | 3,379 | 7,873 | 203,362 | Apr 03, 2018, 07:52 AM |
| McMahon Gerald PhD | Director | Mar 01, 2018 | Option Exercise | $2.25 | 3,415 | 7,684 | 206,741 | Mar 02, 2018, 07:49 AM |
| McMahon Gerald PhD | Director | Feb 01, 2018 | Option Exercise | $2.76 | 3,415 | 9,425 | 210,156 | Feb 02, 2018, 07:35 AM |
| McMahon Gerald PhD | Director | Jan 02, 2018 | Option Exercise | $2.84 | 3,665 | 10,409 | 213,571 | Jan 03, 2018, 06:59 AM |
| McMahon Gerald PhD | Director | Dec 01, 2017 | Option Exercise | $3.00 | 3,212 | 9,636 | 217,236 | Dec 01, 2017, 08:27 AM |
| McMahon Gerald PhD | Director | Nov 01, 2017 | Option Exercise | $2.44 | 3,212 | 7,837 | 220,448 | Nov 02, 2017, 08:23 AM |
| McMahon Gerald PhD | Director | Oct 02, 2017 | Option Exercise | $2.86 | 3,212 | 9,186 | 223,660 | Oct 02, 2017, 04:09 PM |
| McMahon Gerald PhD | Director | Sep 01, 2017 | Option Exercise | $2.46 | 3,212 | 7,902 | 226,872 | Sep 05, 2017, 08:17 AM |
| McMahon Gerald PhD | Director | Aug 01, 2017 | Option Exercise | $2.29 | 2,869 | 6,570 | 230,084 | Aug 01, 2017, 04:30 PM |
| McMahon Gerald PhD | Director | Jul 03, 2017 | Option Exercise | $2.47 | 2,869 | 7,086 | 232,953 | Jul 05, 2017, 04:32 PM |
| McMahon Gerald PhD | Director | Jun 01, 2017 | Option Exercise | $2.83 | 2,869 | 8,119 | 225,822 | Jun 01, 2017, 08:09 AM |
| McMahon Gerald PhD | Director | May 01, 2017 | Option Exercise | $3.33 | 2,869 | 9,554 | 228,691 | May 01, 2017, 04:01 PM |
| McMahon Gerald PhD | Director | Apr 03, 2017 | Option Exercise | $3.61 | 2,869 | 10,357 | 231,560 | Apr 03, 2017, 04:37 PM |
| McMahon Gerald PhD | Director | Mar 01, 2017 | Option Exercise | $3.54 | 32,927 | 116,562 | 234,429 | Mar 03, 2017, 09:10 AM |
| CATLIN AVERY W | Sr. VP & CFO | Sep 02, 2016 | Option Exercise | $2.80 | 10,000 | 28,000 | 83,586 | Sep 07, 2016, 12:59 PM |
| KELER TIBOR | Executive VP & CSO | Sep 02, 2016 | Buy | $3.32 | 3,000 | 9,960 | 18,868 | Sep 06, 2016, 01:04 PM |
| CATLIN AVERY W | Sr. VP & CFO | Jun 03, 2016 | Option Exercise | $3.01 | 22,847 | 68,811 | 73,586 | Jun 06, 2016, 08:26 AM |
| CATLIN AVERY W | Sr. VP & CFO | Mar 09, 2016 | Option Exercise | $2.80 | 15,000 | 42,000 | 50,739 | Mar 10, 2016, 07:59 AM |
| CATLIN AVERY W | Sr. VP & CFO | Nov 23, 2015 | Option Exercise | $8.52 | 25,000 | 213,000 | 60,109 | Nov 25, 2015, 04:09 PM |
| CATLIN AVERY W | Sr. VP & CFO | Nov 23, 2015 | Sale | $18.00 | 25,000 | 450,000 | 35,109 | Nov 25, 2015, 04:09 PM |
| CATLIN AVERY W | Sr. VP & CFO | Sep 11, 2015 | Option Exercise | $4.50 | 10,000 | 45,000 | 35,109 | Sep 14, 2015, 08:21 AM |
| ELLBERGER LARRY | Director | Aug 25, 2015 | Buy | $14.00 | 5,000 | 70,000 | 53,500 | Aug 26, 2015, 04:35 PM |
| ELLBERGER LARRY | Director | Aug 20, 2015 | Buy | $15.00 | 5,000 | 75,000 | 48,500 | Aug 21, 2015, 07:01 AM |
| ELLBERGER LARRY | Director | Aug 18, 2015 | Buy | $15.95 | 5,000 | 79,747 | 43,500 | Aug 19, 2015, 07:33 AM |
| ELLBERGER LARRY | Director | Aug 13, 2015 | Buy | $16.59 | 5,000 | 82,950 | 38,500 | Aug 14, 2015, 08:02 AM |
| Marucci Anthony S | President and CEO | Aug 13, 2015 | Buy | $16.81 | 5,800 | 97,497 | 50,028 | Aug 14, 2015, 08:01 AM |
| CATLIN AVERY W | Sr. VP & CFO | Jun 15, 2015 | Option Exercise | $8.52 | 25,000 | 213,000 | 49,609 | Jun 16, 2015, 04:19 PM |
| CATLIN AVERY W | Sr. VP & CFO | Jun 15, 2015 | Sale | $24.59 | 25,000 | 614,752 | 24,609 | Jun 16, 2015, 04:19 PM |
| CATLIN AVERY W | Sr. VP & CFO | Sep 08, 2014 | Option Exercise | $4.50 | 10,000 | 45,000 | 24,609 | Sep 09, 2014, 01:53 PM |
| LIPTON KAREN SHOOS | Director | Dec 06, 2013 | Option Exercise | $8.16 | 17,728 | 144,660 | 31,061 | Dec 10, 2013, 04:20 PM |
| LIPTON KAREN SHOOS | Director | Dec 06, 2013 | Sale | $24.50 | 17,728 | 434,336 | 13,333 | Dec 10, 2013, 04:20 PM |
| PENNER HARRY JR | Director | Dec 06, 2013 | Option Exercise | $8.16 | 17,728 | 144,660 | 31,144 | Dec 10, 2013, 04:15 PM |
| PENNER HARRY JR | Director | Dec 06, 2013 | Sale | $24.50 | 17,728 | 434,336 | 13,416 | Dec 10, 2013, 04:15 PM |
| ELLBERGER LARRY | Director | Dec 06, 2013 | Option Exercise | $8.16 | 17,728 | 144,660 | 42,728 | Dec 10, 2013, 04:15 PM |
| ELLBERGER LARRY | Director | Dec 06, 2013 | Sale | $24.50 | 17,728 | 434,336 | 25,000 | Dec 10, 2013, 04:15 PM |
| CATLIN AVERY W | Sr. VP & CFO | Dec 06, 2013 | Option Exercise | $8.16 | 183,333 | 1,495,997 | 197,442 | Dec 10, 2013, 04:15 PM |
| CATLIN AVERY W | Sr. VP & CFO | Dec 06, 2013 | Sale | $24.50 | 183,333 | 4,491,659 | 14,109 | Dec 10, 2013, 04:15 PM |
| CATLIN AVERY W | Sr. VP & CFO | Jul 01, 2013 | Option Exercise | $5.95 | 500 | 2,975 | 14,109 | Jul 03, 2013, 08:51 AM |
| Marucci Anthony S | President & CEO | Jul 01, 2013 | Option Exercise | $5.95 | 500 | 2,975 | 43,368 | Jul 03, 2013, 08:51 AM |
| KELER TIBOR | Sr. VP & CSO | Aug 11, 2011 | Buy | $2.50 | 5,000 | 12,520 | 15,868 | Aug 11, 2011, 01:42 PM |
| Marucci Anthony S | President & CEO | Aug 09, 2011 | Buy | $2.41 | 15,000 | 36,160 | 5,000 | Aug 10, 2011, 09:54 AM |
| CATLIN AVERY W | Sr. VP & CFO | Aug 09, 2011 | Buy | $2.39 | 2,000 | 4,780 | 2,000 | Aug 10, 2011, 09:52 AM |
| Davis Thomas Andrew | Sr. VP & CMO | Sep 16, 2010 | Buy | $3.77 | 2,500 | 9,435 | 1,489 | Sep 17, 2010, 09:15 AM |
| LIPTON KAREN SHOOS | Director | Sep 16, 2010 | Buy | $3.74 | 3,000 | 11,220 | 3,000 | Sep 16, 2010, 01:16 PM |
| PAREKH RAJESH R | Director | Sep 13, 2010 | Buy | $3.73 | 40,000 | 149,348 | 40,000 | Sep 14, 2010, 01:39 PM |
| KELER TIBOR | Sr. VP & CSO | Sep 13, 2010 | Buy | $3.52 | 5,000 | 17,600 | 5,000 | Sep 13, 2010, 10:41 AM |
| Marucci Anthony S | President & CEO | Sep 10, 2010 | Buy | $3.45 | 11,700 | 40,351 | 2,500 | Sep 13, 2010, 10:24 AM |
| SHANNON TIMOTHY M | Director | Sep 10, 2010 | Buy | $3.41 | 5,000 | 17,049 | 3,200 | Sep 13, 2010, 09:37 AM |
| SCHALLER CHARLES R | Director | Sep 09, 2010 | Buy | $3.45 | 5,000 | 17,250 | 5,000 | Sep 13, 2010, 09:18 AM |
| PENNER HARRY JR | Director | Sep 09, 2010 | Buy | $3.49 | 3,000 | 10,470 | 3,000 | Sep 09, 2010, 02:19 PM |
| CATLIN AVERY W | Sr. VP & CFO | Sep 08, 2010 | Buy | $3.51 | 2,000 | 7,016 | 2,000 | Sep 09, 2010, 11:57 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Jimenez Freddy A. | SVP & GENERAL COUNSEL | 02/13/2024 | 93,163 |
| Martin Samuel Bates | SVP AND CFO | 01/02/2024 | 29,885 |
| KELER TIBOR | EXECUTIVE VP & CSO | 12/07/2022 | 46,871 |
| KELER TIBOR | EXECUTIVE VP & CSO | 12/07/2022 | 622,611 |
| Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | 08/18/2022 | 12,217 |
| Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | 08/17/2022 | 87,047 |
| Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | 08/17/2022 | 1,150,221 |
| Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | 08/18/2022 | 49,289 |
| Young Diane C. | SVP, CHIEF MEDICAL OFFICER | 08/17/2022 | 319,170 |
| Young Diane C. | SVP, CHIEF MEDICAL OFFICER | 08/17/2022 | 708,715 |
| Wright Richard M. | SR. VP & CCO | 08/15/2022 | 159,105 |
| Wright Richard M. | SR. VP & CCO | 08/15/2022 | 578,048 |
| Martin Samuel Bates | SVP AND CFO | 08/12/2022 | 72,953 |
| Martin Samuel Bates | SVP AND CFO | 08/11/2022 | 22,117 |
| Martin Samuel Bates | SVP AND CFO | 08/12/2022 | 639,629 |
| Martin Samuel Bates | SVP AND CFO | 08/11/2022 | 90,856 |
| Martin Samuel Bates | SVP and CFO | 12/23/2021 | 39,729 |
| Martin Samuel Bates | SVP and CFO | 12/23/2021 | 399,000 |
| Cavanaugh Sarah | SVP of Corp Affairs & Admin. | 12/08/2021 | 73,481 |
| Cavanaugh Sarah | SVP of Corp Affairs & Admin. | 12/08/2021 | 292,920 |
| Crowley Elizabeth | Sr. VP &CPDO | 12/08/2021 | 36,066 |
| Crowley Elizabeth | Sr. VP &CPDO | 12/08/2021 | 160,000 |
| Heath-Chiozzi Margo | SVP of Regulatory Affairs | 12/08/2021 | 1,668 |
| Heath-Chiozzi Margo | SVP of Regulatory Affairs | 12/08/2021 | 24,000 |
| Martin Samuel Bates | SVP and CFO | 11/15/2021 | 39,729 |
| Martin Samuel Bates | SVP and CFO | 11/15/2021 | 413,883 |
| Young Diane C. | SVP, Chief Medical Officer | 11/12/2021 | 47,748 |
| Young Diane C. | SVP, Chief Medical Officer | 11/12/2021 | 197,529 |
| Cavanaugh Sarah | SVP of Corp Affairs & Admin. | 11/01/2021 | 47,852 |
| Cavanaugh Sarah | SVP of Corp Affairs & Admin. | 11/01/2021 | 316,804 |
| Crowley Elizabeth | Sr. VP &CPDO | 11/01/2021 | 23,783 |
| Crowley Elizabeth | Sr. VP &CPDO | 11/01/2021 | 186,874 |
| Heath-Chiozzi Margo | SVP of Regulatory Affairs | 11/01/2021 | 1,668 |
| Heath-Chiozzi Margo | SVP of Regulatory Affairs | 11/01/2021 | 25,026 |
| Heath-Chiozzi Margo | SVP of Regulatory Affairs | 08/11/2021 | 90,165 |
| Jimenez Freddy A. | SVP & General Counsel | 08/11/2021 | 19,900 |
| Martin Samuel Bates | SVP and CFO | 08/10/2021 | 123,688 |
| Martin Samuel Bates | SVP and CFO | 08/10/2021 | 123,895 |
| Marucci Anthony S | President & CEO | 08/05/2021 | 148,554 |
| Wright Richard M. | Sr. VP & CCO | 12/14/2020 | 129,365 |
| Wright Richard M. | Sr. VP & CCO | 12/14/2020 | 387,611 |
| Young Diane C. | SVP, Chief Medical Officer | 06/11/2020 | 10,004 |
| Cavanaugh Sarah | SVP of Corp Affairs & Admin. | 06/10/2020 | 5,071 |
| Heath-Chiozzi Margo | SVP of Regulatory Affairs | 06/09/2020 | 3,005 |
| Martin Samuel Bates | SVP and CFO | 06/09/2020 | 29,737 |
| MARINO JAMES J | Director | 06/09/2020 | 24,915 |
| KELER TIBOR | Executive VP & CSO | 06/09/2020 | 14,954 |
| Marucci Anthony S | President & CEO | 06/09/2020 | 45,900 |
| McMahon Gerald PhD | Director | 12/03/2018 | 843 |
| McMahon Gerald PhD | Director | 11/01/2018 | 908 |
| McMahon Gerald PhD | Director | 10/01/2018 | 1,302 |
| McMahon Gerald PhD | Director | 09/04/2018 | 1,412 |
| MARINO JAMES J | Director | 08/24/2018 | 19,200 |
| McMahon Gerald PhD | Director | 08/01/2018 | 1,308 |
| McMahon Gerald PhD | Director | 07/02/2018 | 1,417 |
| KELER TIBOR | Executive VP & CSO | 06/15/2018 | 9,783 |
| McMahon Gerald PhD | Director | 06/01/2018 | 1,632 |
| McMahon Gerald PhD | Director | 05/01/2018 | 2,082 |
| McMahon Gerald PhD | Director | 04/02/2018 | 7,873 |
| McMahon Gerald PhD | Director | 03/01/2018 | 7,684 |
| McMahon Gerald PhD | Director | 02/01/2018 | 9,425 |
| McMahon Gerald PhD | Director | 01/02/2018 | 10,409 |
| McMahon Gerald PhD | Director | 12/01/2017 | 9,636 |
| McMahon Gerald PhD | Director | 11/01/2017 | 7,837 |
| McMahon Gerald PhD | Director | 10/02/2017 | 9,186 |
| McMahon Gerald PhD | Director | 09/01/2017 | 7,902 |
| McMahon Gerald PhD | Director | 08/01/2017 | 6,570 |
| McMahon Gerald PhD | Director | 07/03/2017 | 7,086 |
| McMahon Gerald PhD | Director | 06/01/2017 | 8,119 |
| McMahon Gerald PhD | Director | 05/01/2017 | 9,554 |
| McMahon Gerald PhD | Director | 04/03/2017 | 10,357 |
| McMahon Gerald PhD | Director | 03/01/2017 | 116,562 |
| CATLIN AVERY W | Sr. VP & CFO | 09/02/2016 | 28,000 |
| KELER TIBOR | Executive VP & CSO | 09/02/2016 | 9,960 |
| CATLIN AVERY W | Sr. VP & CFO | 06/03/2016 | 68,811 |
| CATLIN AVERY W | Sr. VP & CFO | 03/09/2016 | 42,000 |
| CATLIN AVERY W | Sr. VP & CFO | 11/23/2015 | 213,000 |
| CATLIN AVERY W | Sr. VP & CFO | 11/23/2015 | 450,000 |
| CATLIN AVERY W | Sr. VP & CFO | 09/11/2015 | 45,000 |
| ELLBERGER LARRY | Director | 08/25/2015 | 70,000 |
| ELLBERGER LARRY | Director | 08/20/2015 | 75,000 |
| ELLBERGER LARRY | Director | 08/18/2015 | 79,747 |
| ELLBERGER LARRY | Director | 08/13/2015 | 82,950 |
| Marucci Anthony S | President and CEO | 08/13/2015 | 97,497 |
| CATLIN AVERY W | Sr. VP & CFO | 06/15/2015 | 213,000 |
| CATLIN AVERY W | Sr. VP & CFO | 06/15/2015 | 614,752 |
| CATLIN AVERY W | Sr. VP & CFO | 09/08/2014 | 45,000 |
| LIPTON KAREN SHOOS | Director | 12/06/2013 | 144,660 |
| LIPTON KAREN SHOOS | Director | 12/06/2013 | 434,336 |
| PENNER HARRY JR | Director | 12/06/2013 | 144,660 |
| PENNER HARRY JR | Director | 12/06/2013 | 434,336 |
| ELLBERGER LARRY | Director | 12/06/2013 | 144,660 |
| ELLBERGER LARRY | Director | 12/06/2013 | 434,336 |
| CATLIN AVERY W | Sr. VP & CFO | 12/06/2013 | 1,495,997 |
| CATLIN AVERY W | Sr. VP & CFO | 12/06/2013 | 4,491,659 |
| CATLIN AVERY W | Sr. VP & CFO | 07/01/2013 | 2,975 |
| Marucci Anthony S | President & CEO | 07/01/2013 | 2,975 |
| KELER TIBOR | Sr. VP & CSO | 08/11/2011 | 12,520 |
| Marucci Anthony S | President & CEO | 08/09/2011 | 36,160 |
| CATLIN AVERY W | Sr. VP & CFO | 08/09/2011 | 4,780 |
| Davis Thomas Andrew | Sr. VP & CMO | 09/16/2010 | 9,435 |
| LIPTON KAREN SHOOS | Director | 09/16/2010 | 11,220 |
| PAREKH RAJESH R | Director | 09/13/2010 | 149,348 |
| KELER TIBOR | Sr. VP & CSO | 09/13/2010 | 17,600 |
| Marucci Anthony S | President & CEO | 09/10/2010 | 40,351 |
| SHANNON TIMOTHY M | Director | 09/10/2010 | 17,049 |
| SCHALLER CHARLES R | Director | 09/09/2010 | 17,250 |
| PENNER HARRY JR | Director | 09/09/2010 | 10,470 |
| CATLIN AVERY W | Sr. VP & CFO | 09/08/2010 | 7,016 |
Load More Insider Transactions
FUNDS WITH A POSITION IN CELLDEX THERAPEUTICS INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 3,675,692 | 0.00372% | 13.03% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,117,994 | 0.00464% | 11.75% | Other |
| CANDRIAM S.C.A. | 317,509 | 0.09% | -1.55% | Other |
| BAKER BROS. ADVISORS LP | 247,644 | 0.11% | New | Other |
| ORBIMED ADVISORS LLC | 58,800 | 0.05% | New | Other |
| ALPS ADVISORS INC | 37,645 | 0.01% | 8.03% | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 24,119 | 0.0018% | -12.02% | Event Driven |
| D. E. SHAW & CO., INC. | 23,746 | 0.00082% | -35.44% | Other |
| FISHER ASSET MANAGEMENT, LLC | 21,812 | 0.00046% | 6.2% | Other |
| TUDOR INVESTMENT CORP ET AL | 14,542 | 0.00464% | -34.01% | Event Driven, Other |
CHANGE IN SHARES OUTSTANDING FOR CELLDEX THERAPEUTICS INC.
STOCK BUYBACKS FOR CELLDEX THERAPEUTICS INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
10.17%
1Q
06/30/2023
10.19%
2Q
03/31/2023
10.28%
3Q
12/31/2022
10.47%
4Q
09/30/2022
10.98%
5Q
06/30/2022
11.35%
6Q
03/31/2022
11.40%
7Q
12/31/2021
11.41%
8Q
09/30/2021
14.55%
9Q
06/30/2021
31.43%
10Q
03/31/2021
31.44%
11Q
12/31/2020
75.66%
12Q
09/30/2020
32.56%
13Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CELLDEX THERAPEUTICS INC.
LOADING...